BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Affymax, Inc. Announces Second Quarter 2012 Financial Results Teleconference and Webcast

  July 31, 2012

   · 

  1 min read
• Policy

  EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited, Others Over Generics

  July 31, 2012

   · 

  1 min read
• Business

  Bayer AG Lifts Guidance, Provisions Weigh on Earnings

  July 31, 2012

   · 

  1 min read
• Pharm Country

  Rim a Dog? Pfizer Inc. Extends an Invitation

  July 31, 2012

   · 

  1 min read
• Business

  Deinove Appoints Julien Coste as Director of Finance & Administration

  July 31, 2012

   · 

  2 min read
• Policy

  MolecularMD Submits Premarketing Approval Application to the FDA for Its BCR-ABL T315I Mutation Test, a Companion Diagnostic to Ponatinib, an Investigational BCR-ABL Inhibitor

  July 31, 2012

   · 

  3 min read
• Drug Development

  Nymox Pharmaceutical Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug

  July 31, 2012

   · 

  1 min read
• Lone Star Bio

  Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas

  July 31, 2012

   · 

  1 min read
• Business

  Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces Second Quarter 2012 Financial Results and Corporate Update Conference Call

  July 31, 2012

   · 

  1 min read
• Business

  Amarin Corporation PLC to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012

  July 31, 2012

   · 

  1 min read